It was reported that MHC-I antigen presentation is downregulated in cancer cells of epithelial origin by abnormalities in the antigen processing machinery [41], which include MHC-I heavy chains, β2M, immunoproteasome subunits, TAP, Tapasin, and ERAP1. Here, B2M is linked to cancer.